NYSE:NVRO - Nevro Stock Price, Price Target & More

$88.79 -0.73 (-0.82 %)
(As of 04/24/2018 04:00 PM ET)
Previous Close$89.52
Today's Range$87.57 - $90.55
52-Week Range$65.00 - $97.70
Volume215,864 shs
Average Volume344,469 shs
Market Capitalization$2.71 billion
P/E Ratio-71.03
Dividend YieldN/A
Beta-0.52

About Nevro (NYSE:NVRO)

Nevro logoNevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.

Receive NVRO News and Ratings via Email

Sign-up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNYSE:NVRO
CUSIPN/A
Phone650-251-0005

Debt

Debt-to-Equity Ratio0.58%
Current Ratio7.61%
Quick Ratio5.91%

Price-To-Earnings

Trailing P/E Ratio-71.03
Forward P/E Ratio-116.83
P/E GrowthN/A

Sales & Book Value

Annual Sales$326.67 million
Price / Sales8.11
Cash FlowN/A
Price / CashN/A
Book Value$8.41 per share
Price / Book10.56

Profitability

EPS (Most Recent Fiscal Year)($1.25)
Net Income$-36,650,000.00
Net Margins-11.22%
Return on Equity-15.01%
Return on Assets-8.47%

Miscellaneous

Employees676
Outstanding Shares29,840,000

How to Become a New Pot Stock Millionaire

Nevro (NYSE:NVRO) Frequently Asked Questions

What is Nevro's stock symbol?

Nevro trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVRO."

How were Nevro's earnings last quarter?

Nevro (NYSE:NVRO) posted its earnings results on Thursday, February, 22nd. The medical equipment provider reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.01. The medical equipment provider earned $97.96 million during the quarter, compared to the consensus estimate of $96.87 million. Nevro had a negative return on equity of 15.01% and a negative net margin of 11.22%. The firm's revenue was up 38.9% compared to the same quarter last year. During the same period last year, the company posted ($0.34) EPS. View Nevro's Earnings History.

When is Nevro's next earnings date?

Nevro is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Nevro.

What price target have analysts set for NVRO?

8 equities research analysts have issued 12 month target prices for Nevro's stock. Their forecasts range from $83.00 to $110.00. On average, they anticipate Nevro's share price to reach $97.6250 in the next twelve months. View Analyst Ratings for Nevro.

Who are some of Nevro's key competitors?

Who are Nevro's key executives?

Nevro's management team includes the folowing people:
  • Mr. Rami Elghandour, Pres, CEO & Director (Age 39)
  • Mr. Andrew H. Galligan, Chief Financial Officer (Age 62)
  • Mr. Patrick Schmitz, VP of Operations (Age 58)
  • Mr. Doug Alleavitch, VP of Quality (Age 57)
  • Mr. Christofer Christoforou, VP of R&D (Age 48)

Has Nevro been receiving favorable news coverage?

Headlines about NVRO stock have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nevro earned a media sentiment score of 0.10 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 44.56 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Nevro?

Shares of NVRO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nevro's stock price today?

One share of NVRO stock can currently be purchased for approximately $88.79.

How big of a company is Nevro?

Nevro has a market capitalization of $2.71 billion and generates $326.67 million in revenue each year. The medical equipment provider earns $-36,650,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis. Nevro employs 676 workers across the globe.

How can I contact Nevro?

Nevro's mailing address is 1800 BRIDGE PARKWAY, REDWOOD CITY CA, 94065. The medical equipment provider can be reached via phone at 650-251-0005 or via email at [email protected]com.


MarketBeat Community Rating for Nevro (NVRO)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  289 (Vote Outperform)
Underperform Votes:  148 (Vote Underperform)
Total Votes:  437
MarketBeat's community ratings are surveys of what our community members think about Nevro and other stocks. Vote "Outperform" if you believe NVRO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVRO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Nevro (NYSE:NVRO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Nevro in the last 12 months. Their average twelve-month price target is $97.6250, suggesting that the stock has a possible upside of 9.95%. The high price target for NVRO is $110.00 and the low price target for NVRO is $83.00. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.862.862.86
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $97.6250$99.7143$99.7143$102.00
Price Target Upside: 9.95% upside46.21% upside46.21% upside10.63% upside

Nevro (NYSE:NVRO) Consensus Price Target History

Price Target History for Nevro (NYSE:NVRO)

Nevro (NYSE:NVRO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/4/2018Goldman SachsInitiated CoverageNeutral -> Neutral$83.00LowView Rating Details
12/14/2017BMO Capital MarketsReiterated RatingBuy$100.00HighView Rating Details
11/7/2017Canaccord GenuityLower Price TargetBuy$120.00 -> $110.00N/AView Rating Details
11/7/2017Northland SecuritiesReiterated RatingBuy$96.00N/AView Rating Details
11/7/2017Leerink SwannReiterated RatingOutperform$105.00 -> $110.00N/AView Rating Details
8/8/2017Morgan StanleyBoost Price TargetOverweight$87.00 -> $95.00MediumView Rating Details
7/3/2017JPMorgan ChaseReiterated RatingOverweight$102.00LowView Rating Details
5/14/2017B. RileyDowngradeNeutral$85.00LowView Rating Details
8/11/2016Piper JaffrayReiterated RatingOverweight$98.00 -> $112.00N/AView Rating Details
8/9/2016JMP SecuritiesBoost Price TargetMarket Outperform$90.00 -> $110.00N/AView Rating Details
8/8/2016Bank of AmericaInitiated CoverageBuy$100.00N/AView Rating Details
7/19/2016William BlairInitiated CoverageOutperformN/AView Rating Details
7/12/2016Wells FargoInitiated CoverageOutperformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Nevro (NYSE:NVRO) Earnings History and Estimates Chart

Earnings by Quarter for Nevro (NYSE:NVRO)

Nevro (NYSE:NVRO) Earnings Estimates

2018 EPS Consensus Estimate: ($0.44)
2019 EPS Consensus Estimate: ($0.14)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.34)($0.13)($0.24)
Q2 20182($0.23)($0.06)($0.15)
Q3 20182($0.16)($0.03)($0.10)
Q4 20181$0.04$0.04$0.04
Q1 20192($0.33)$0.02($0.16)
Q2 20192($0.13)$0.04($0.05)
Q3 20192($0.06)$0.01($0.03)
Q4 20192$0.04$0.14$0.09

Nevro (NYSE NVRO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018($0.32)N/AView Earnings Details
2/22/2018Q4 2017($0.14)($0.15)$96.87 million$97.96 millionViewListenView Earnings Details
11/6/2017Q3 2017($0.23)($0.21)$80.50 million$82.26 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.29)($0.40)$77.75 million$78.02 millionViewListenView Earnings Details
5/8/2017Q1 2017($0.26)($0.50)$68.71 million$68.40 millionViewListenView Earnings Details
2/23/2017Q416($0.20)($0.34)$66.41 million$70.50 millionViewN/AView Earnings Details
11/7/2016Q316($0.39)($0.14)$58.05 million$60.92 millionViewListenView Earnings Details
8/8/2016Q216($0.47)($0.31)$45.11 million$55.40 millionViewN/AView Earnings Details
5/9/2016Q116($0.65)($0.33)$33.48 million$41.65 millionViewN/AView Earnings Details
2/29/2016Q415($0.56)($0.51)$32.88 million$33.10 millionViewListenView Earnings Details
11/9/2015Q315($0.75)($0.70)$12.51 million$15.40 millionViewN/AView Earnings Details
8/6/2015Q215($0.89)($0.77)$9.65 million$11.40 millionViewN/AView Earnings Details
5/11/2015Q1($0.5430)($0.57)$8.20 million$9.66 millionViewListenView Earnings Details
3/18/2015Q4 2014($0.51)($0.59)$9.72 millionViewN/AView Earnings Details
12/2/2014Q3 2014($0.48)$8.67 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Nevro (NYSE:NVRO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Nevro (NYSE NVRO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.90%
Insider Trading History for Nevro (NYSE:NVRO)
Institutional Ownership by Quarter for Nevro (NYSE:NVRO)

Nevro (NYSE NVRO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2018Wilfred E JaegerDirectorSell160,542$80.77$12,966,977.341,518View SEC Filing  
3/5/2018Wilfred E JaegerDirectorSell42,116$80.19$3,377,282.041,518View SEC Filing  
3/1/2018Andrew H. GalliganCFOSell7,000$80.10$560,700.00View SEC Filing  
3/1/2018Wilfred E JaegerDirectorSell10,000$80.48$804,800.001,518View SEC Filing  
2/27/2018Wilfred E JaegerDirectorSell14,458$83.28$1,204,062.241,518View SEC Filing  
11/14/2017Andrew H GalliganCFOSell7,000$75.11$525,770.00View SEC Filing  
10/5/2017Michael F DemaneDirectorSell5,000$93.50$467,500.00View SEC Filing  
9/27/2017Michael F. DemaneDirectorSell5,000$91.50$457,500.00View SEC Filing  
9/14/2017Wilfred E JaegerDirectorSell16,467$90.19$1,485,158.731,518View SEC Filing  
9/13/2017Michael F. DemaneDirectorSell5,000$89.50$447,500.00View SEC Filing  
9/11/2017Michael F. DemaneDirectorSell25,000$87.73$2,193,250.00View SEC Filing  
8/24/2017Wilfred E JaegerDirectorSell52,520$86.11$4,522,497.201,518View SEC Filing  
8/21/2017Wilfred E JaegerDirectorSell40,343$84.28$3,400,108.041,518View SEC Filing  
8/16/2017Wilfred E. JaegerDirectorSell79,657$82.74$6,590,820.18View SEC Filing  
8/15/2017Wilfred E. JaegerDirectorSell29,665$82.54$2,448,549.10View SEC Filing  
8/14/2017Andrew H. GalliganCFOSell7,000$82.31$576,170.00View SEC Filing  
8/14/2017Wilfred E. JaegerDirectorSell25,255$82.40$2,081,012.00View SEC Filing  
5/15/2017Andrew H. GalliganCFOSell7,500$75.30$564,750.00View SEC Filing  
5/2/2017Michael F DemaneDirectorSell29,800$96.07$2,862,886.00501,795View SEC Filing  
5/1/2017Rami ElghandourCEOSell10,000$95.03$950,300.00View SEC Filing  
4/4/2017Michael EnxingVPSell1,500$93.53$140,295.00View SEC Filing  
4/4/2017Michael F DemaneDirectorSell22,200$93.39$2,073,258.00517,795View SEC Filing  
4/3/2017Andrew H. GalliganCFOSell30,000$94.46$2,833,800.00View SEC Filing  
3/6/2017Michael EnxingVPSell38,500$91.01$3,503,885.00View SEC Filing  
3/3/2017Wilfred E JaegerDirectorSell43,980$95.03$4,179,419.40View SEC Filing  
1/4/2017Michael EnxingVPSell1,500$75.88$113,820.00View SEC Filing  
12/5/2016Michael EnxingVPSell1,500$76.38$114,570.00View SEC Filing  
11/15/2016Andrew H GalliganCFOSell7,500$86.90$651,750.0033,315View SEC Filing  
10/10/2016Rami ElghandourCEOSell3,000$100.00$300,000.00View SEC Filing  
10/6/2016Michael F DemaneDirectorSell139,514$97.46$13,597,034.44532,425View SEC Filing  
10/4/2016Michael EnxingVPSell1,500$99.31$148,965.0039,463View SEC Filing  
8/22/2016Doug AlleavitchVPSell3,000$100.00$300,000.005,961View SEC Filing  
8/22/2016Wilfred E JaegerDirectorSell154,840$97.79$15,141,803.60View SEC Filing  
8/17/2016Wilfred E JaegerDirectorSell155,160$97.31$15,098,619.60View SEC Filing  
8/15/2016Andrew H GalliganCFOSell7,500$97.71$732,825.0030,079View SEC Filing  
8/10/2016Doug AlleavitchVPSell2,500$95.00$237,500.006,961View SEC Filing  
8/9/2016Michael F DemaneDirectorSell26,667$91.50$2,440,030.50499,252View SEC Filing  
8/4/2016Michael EnxingVPSell1,500$82.06$123,090.0039,463View SEC Filing  
7/29/2016Doug AlleavitchVPSell1,000$85.00$85,000.007,961View SEC Filing  
7/29/2016Michael F DemaneDirectorSell13,333$84.00$1,119,972.00505,919View SEC Filing  
7/11/2016Doug AlleavitchVPSell2,000$80.00$160,000.008,961View SEC Filing  
7/11/2016Michael F DemaneDirectorSell13,333$79.00$1,053,307.00512,586View SEC Filing  
7/5/2016Michael EnxingVPSell1,500$75.39$113,085.0039,463View SEC Filing  
7/1/2016Michael F DemaneDirectorSell13,333$74.00$986,642.00519,253View SEC Filing  
6/8/2016Doug AlleavitchVPSell1,000$75.00$75,000.009,961View SEC Filing  
6/8/2016Rami ElghandourCEOSell7,000$76.59$536,130.0071,180View SEC Filing  
6/6/2016Michael EnxingVPSell1,500$73.29$109,935.0039,463View SEC Filing  
6/2/2016Andre WalkerVPSell4,000$73.50$294,000.004,197View SEC Filing  
6/1/2016Doug AlleavitchVPSell500$72.00$36,000.0010,961View SEC Filing  
5/18/2016Wilfred E JaegerDirectorSell112,983$64.68$7,307,740.44View SEC Filing  
5/16/2016Andrew H GalliganCFOSell10,000$64.78$647,800.0040,000View SEC Filing  
5/16/2016Michael F DemaneCEOSell39,999$64.77$2,590,735.23525,920View SEC Filing  
5/12/2016Rami ElghandourPresidentSell7,000$63.93$447,510.0068,024View SEC Filing  
5/4/2016Michael EnxingVPSell1,500$65.06$97,590.0038,913View SEC Filing  
4/4/2016Michael EnxingVPSell8,767$61.59$539,959.5346,180View SEC Filing  
4/1/2016Rami ElghandourPresidentSell7,000$60.99$426,930.0071,180View SEC Filing  
1/11/2016Andre WalkerVPSell7,987$70.75$565,080.25470View SEC Filing  
1/4/2016Doug AlleavitchVPSell2,514$66.47$167,105.5811,470View SEC Filing  
12/17/2015Andre WalkerVPSell13$69.00$897.00470View SEC Filing  
12/7/2015Rami ElghandourPresidentSell3,500$61.82$216,370.00View SEC Filing  
12/2/2015Andre WalkerVPSell1,000$64.00$64,000.00470View SEC Filing  
12/1/2015Andre WalkerVPSell8,000$59.50$476,000.00470View SEC Filing  
11/30/2015Andre WalkerVPSell6,000$58.50$351,000.00470View SEC Filing  
11/30/2015Rami ElghandourPresidentSell3,500$60.00$210,000.00View SEC Filing  
11/24/2015Andre WalkerVPSell1,000$55.00$55,000.00470View SEC Filing  
11/23/2015Andre WalkerVPSell1,000$54.00$54,000.00470View SEC Filing  
11/23/2015Wilfred E JaegerDirectorSell25,000$53.48$1,337,000.00View SEC Filing  
11/18/2015Wilfred E JaegerDirectorSell175,000$52.24$9,142,000.00View SEC Filing  
11/16/2015Michael F DemaneCEOSell26,667$50.52$1,347,216.84573,941View SEC Filing  
11/13/2015Brad ValeDirectorBuy2,000$50.76$101,520.002,000View SEC Filing  
9/17/2015Andre WalkerVPSell4,000$50.75$203,000.00View SEC Filing  
9/2/2015Michael F DemaneCEOSell40,001$45.11$1,804,445.11600,608View SEC Filing  
6/8/2015& Johnson JohnsonMajor ShareholderSell1,010,265$47.94$48,432,104.10View SEC Filing  
6/8/2015Bay City Capital LlcInsiderSell491,835$47.94$23,578,569.90View SEC Filing  
6/8/2015Wilfred E JaegerDirectorSell393,468$47.94$18,862,855.92View SEC Filing  
11/12/2014& Johnson JohnsonMajor ShareholderBuy40,000$18.00$720,000.00View SEC Filing  
11/12/2014A/S NovoInsiderBuy215,000$18.00$3,870,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Nevro (NYSE NVRO) News Headlines

Source:
DateHeadline
Nevro to Report Operating Results for the First Quarter 2018Nevro to Report Operating Results for the First Quarter 2018
finance.yahoo.com - April 23 at 4:42 PM
Zacks: Analysts Anticipate Nevro (NVRO) to Post -$0.34 EPSZacks: Analysts Anticipate Nevro (NVRO) to Post -$0.34 EPS
www.americanbankingnews.com - April 23 at 1:14 AM
Nevro (NVRO) Upgraded by Zacks Investment Research to "Buy"Nevro (NVRO) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 14 at 12:53 PM
Morgan Stanley Boosts Nevro (NVRO) Price Target to $95.00Morgan Stanley Boosts Nevro (NVRO) Price Target to $95.00
www.americanbankingnews.com - April 12 at 5:45 PM
Establishment Labs Appoints Jeremy Livianu as General CounselEstablishment Labs Appoints Jeremy Livianu as General Counsel
globenewswire.com - April 12 at 9:53 AM
Zacks Investment Research Lowers Nevro (NVRO) to HoldZacks Investment Research Lowers Nevro (NVRO) to Hold
www.americanbankingnews.com - April 10 at 7:17 PM
BRIEF-Nevro Corp Says CEO Rami Elghandours FY 2017 Total Compensation Was $13.2 MlnBRIEF-Nevro Corp Says CEO Rami Elghandour's FY 2017 Total Compensation Was $13.2 Mln
www.reuters.com - April 8 at 10:24 AM
$88.57 Million in Sales Expected for Nevro Corp (NVRO) This Quarter$88.57 Million in Sales Expected for Nevro Corp (NVRO) This Quarter
www.americanbankingnews.com - April 8 at 4:48 AM
Investors Buy Large Volume of Call Options on Nevro (NVRO)Investors Buy Large Volume of Call Options on Nevro (NVRO)
www.americanbankingnews.com - April 6 at 7:24 AM
Zacks: Analysts Expect Nevro Corp (NVRO) to Post -$0.34 Earnings Per ShareZacks: Analysts Expect Nevro Corp (NVRO) to Post -$0.34 Earnings Per Share
www.americanbankingnews.com - April 6 at 3:08 AM
Nevro (NVRO) Upgraded at Zacks Investment ResearchNevro (NVRO) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 5 at 11:52 PM
Nevro (NVRO) Earns Hold Rating from Analysts at Goldman SachsNevro (NVRO) Earns Hold Rating from Analysts at Goldman Sachs
www.americanbankingnews.com - April 4 at 8:04 AM
Nevro Corp (NVRO) Given Consensus Rating of "Hold" by BrokeragesNevro Corp (NVRO) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - April 4 at 5:36 AM
Nevro (NVRO) Raised to Hold at ValuEngineNevro (NVRO) Raised to Hold at ValuEngine
www.americanbankingnews.com - April 3 at 11:04 AM
Nevro (NVRO) Raised to "C-" at TheStreetNevro (NVRO) Raised to "C-" at TheStreet
www.americanbankingnews.com - April 1 at 11:23 AM
These medical devices offer hope for treating chronic pain without opioidsThese medical devices offer hope for treating chronic pain without opioids
www.cnbc.com - March 29 at 4:46 PM
Mazor Robotics (MZOR) versus Nevro (NVRO) Financial AnalysisMazor Robotics (MZOR) versus Nevro (NVRO) Financial Analysis
www.americanbankingnews.com - March 27 at 11:24 AM
Full-Body MRI Conditional Labeling Now Available in United States for Nevro Senza® Spinal Cord Stimulation System - PR Newswire (press release)Full-Body MRI Conditional Labeling Now Available in United States for Nevro Senza® Spinal Cord Stimulation System - PR Newswire (press release)
www.prnewswire.com - March 22 at 4:51 PM
Full-Body MRI Conditional Labeling Now Available in United States for Nevro Senza® Spinal Cord Stimulation SystemFull-Body MRI Conditional Labeling Now Available in United States for Nevro Senza® Spinal Cord Stimulation System
finance.yahoo.com - March 22 at 4:51 PM
Nevro Corp (NVRO) Expected to Announce Quarterly Sales of $88.57 MillionNevro Corp (NVRO) Expected to Announce Quarterly Sales of $88.57 Million
www.americanbankingnews.com - March 22 at 10:37 AM
 Analysts Anticipate Nevro Corp (NVRO) to Post -$0.34 EPS Analysts Anticipate Nevro Corp (NVRO) to Post -$0.34 EPS
www.americanbankingnews.com - March 20 at 3:17 AM
Nevro Target of Unusually High Options Trading (NVRO)Nevro Target of Unusually High Options Trading (NVRO)
www.americanbankingnews.com - March 14 at 7:29 AM
Analyzing Nevro (NVRO) and T2 Biosystems (TTOO)Analyzing Nevro (NVRO) and T2 Biosystems (TTOO)
www.americanbankingnews.com - March 13 at 1:18 AM
Wilfred E. Jaeger Sells 42,116 Shares of Nevro Corp (NVRO) StockWilfred E. Jaeger Sells 42,116 Shares of Nevro Corp (NVRO) Stock
www.americanbankingnews.com - March 7 at 6:16 PM
Wilfred E. Jaeger Sells 160,542 Shares of Nevro Corp (NVRO) StockWilfred E. Jaeger Sells 160,542 Shares of Nevro Corp (NVRO) Stock
www.americanbankingnews.com - March 7 at 6:16 PM
Nevro Corp (NVRO) Position Increased by Royce & Associates LPNevro Corp (NVRO) Position Increased by Royce & Associates LP
www.americanbankingnews.com - March 6 at 10:53 AM
Nevro Corp (NVRO) CFO Sells $560,700.00 in StockNevro Corp (NVRO) CFO Sells $560,700.00 in Stock
www.americanbankingnews.com - March 5 at 6:40 PM
Landscape Capital Management L.L.C. Has $1.98 Million Position in Nevro Corp (NVRO)Landscape Capital Management L.L.C. Has $1.98 Million Position in Nevro Corp (NVRO)
www.americanbankingnews.com - March 4 at 2:29 PM
Zacks: Brokerages Expect Nevro Corp (NVRO) Will Announce Quarterly Sales of $88.57 MillionZacks: Brokerages Expect Nevro Corp (NVRO) Will Announce Quarterly Sales of $88.57 Million
www.americanbankingnews.com - March 4 at 2:20 AM
Nevro Corp (NVRO) Expected to Announce Earnings of -$0.34 Per ShareNevro Corp (NVRO) Expected to Announce Earnings of -$0.34 Per Share
www.americanbankingnews.com - March 2 at 11:20 PM
Nevro Corp (NVRO) Director Sells $804,800.00 in StockNevro Corp (NVRO) Director Sells $804,800.00 in Stock
www.americanbankingnews.com - March 1 at 9:30 PM
Nevro Corp (NVRO) Director Sells $1,204,062.24 in StockNevro Corp (NVRO) Director Sells $1,204,062.24 in Stock
www.americanbankingnews.com - March 1 at 9:30 PM
Nevro Corp (NVRO) Shares Sold by Dorsey & Whitney Trust CO LLCNevro Corp (NVRO) Shares Sold by Dorsey & Whitney Trust CO LLC
www.americanbankingnews.com - March 1 at 3:48 PM
Nevro (NVRO) Stock Rating Lowered by Zacks Investment ResearchNevro (NVRO) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - February 28 at 10:52 AM
CT Mason Has $1.52 Million Holdings in Nevro Corp (NVRO)CT Mason Has $1.52 Million Holdings in Nevro Corp (NVRO)
www.americanbankingnews.com - February 26 at 4:01 PM
Nevro Corp (NVRO) Shares Bought by OppenheimerFunds Inc.Nevro Corp (NVRO) Shares Bought by OppenheimerFunds Inc.
www.americanbankingnews.com - February 26 at 1:48 PM
Wells Fargo & Company MN Cuts Holdings in Nevro Corp (NVRO)Wells Fargo & Company MN Cuts Holdings in Nevro Corp (NVRO)
www.americanbankingnews.com - February 26 at 10:10 AM
Leerink Swann Comments on Nevro Corps Q4 2018 Earnings (NVRO)Leerink Swann Comments on Nevro Corp's Q4 2018 Earnings (NVRO)
www.americanbankingnews.com - February 26 at 8:02 AM
Nevro Corp (NVRO) PT Raised to $94 at Morgan StanleyNevro Corp (NVRO) PT Raised to $94 at Morgan Stanley
www.streetinsider.com - February 23 at 5:14 PM
Nevro (NVRO) Issues  Earnings Results, Misses Expectations By $0.01 EPSNevro (NVRO) Issues Earnings Results, Misses Expectations By $0.01 EPS
www.americanbankingnews.com - February 22 at 11:10 PM
Nevro Reports Fourth Quarter and Full Year 2017 Financial Results and Provides 2018 OutlookNevro Reports Fourth Quarter and Full Year 2017 Financial Results and Provides 2018 Outlook
finance.yahoo.com - February 22 at 5:05 PM
Nevro Corp’s (NYSE:NVRO) Earnings Declined -16.68%, But How Did It Fare Against The Industry?Nevro Corp’s (NYSE:NVRO) Earnings Declined -16.68%, But How Did It Fare Against The Industry?
finance.yahoo.com - February 22 at 9:00 AM
$97.62 Million in Sales Expected for Nevro Corp (NVRO) This Quarter$97.62 Million in Sales Expected for Nevro Corp (NVRO) This Quarter
www.americanbankingnews.com - February 16 at 10:28 AM
Nevro (NVRO) Scheduled to Post Quarterly Earnings on ThursdayNevro (NVRO) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - February 15 at 2:56 AM
Nevro Corp (NVRO) Expected to Post Earnings of -$0.14 Per ShareNevro Corp (NVRO) Expected to Post Earnings of -$0.14 Per Share
www.americanbankingnews.com - February 14 at 11:00 AM
Nevro to Report Operating Results for the Fourth Quarter and Full Year 2017Nevro to Report Operating Results for the Fourth Quarter and Full Year 2017
finance.yahoo.com - February 9 at 9:26 AM
Leerink Swann Weighs in on Nevro Corps FY2017 Earnings (NVRO)Leerink Swann Weighs in on Nevro Corp's FY2017 Earnings (NVRO)
www.americanbankingnews.com - February 7 at 6:48 AM
Nevro Corp (NVRO) Expected to Post Q3 2019 Earnings of $0.06 Per ShareNevro Corp (NVRO) Expected to Post Q3 2019 Earnings of $0.06 Per Share
www.americanbankingnews.com - February 6 at 1:58 PM
Nevro (NVRO) Lowered to "Sell" at ValuEngineNevro (NVRO) Lowered to "Sell" at ValuEngine
www.americanbankingnews.com - February 4 at 7:40 PM
 Brokerages Expect Nevro Corp (NVRO) Will Announce Quarterly Sales of $97.60 Million Brokerages Expect Nevro Corp (NVRO) Will Announce Quarterly Sales of $97.60 Million
www.americanbankingnews.com - January 30 at 6:18 AM

SEC Filings

Nevro (NYSE:NVRO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Nevro (NYSE:NVRO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Nevro (NYSE NVRO) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.